Trending...
- California: Governor Newsom announces appointments 9.10.25 - 286
- John Thomas calls for unity and prayer after tragic loss - 261
- Ayurveda, Ayurvedic medical Science and Ayurvedic Therapies, Dr.Abhay Kumar Pati - 251
SAN DIEGO, Sept. 18, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on September 15, 2020, the Compensation Committee of its Board of Directors granted to nine new employees inducement stock options to purchase an aggregate of 68,825 shares of its common stock and 12,420 inducement restricted stock units ("RSUs"). The inducement stock options and RSUs have a grant date and vesting commencement date of September 15, 2020, and were granted as inducements material to the new employees entering into employment with Arena in accordance with Nasdaq Listing Rule 5635(c)(4).
The inducement stock options are non-qualified stock options, have a seven-year term, have an exercise price of $69.25 per share, the closing price of Arena's common stock on the grant date, and vest over four years, with 25% of the shares vesting on the one-year anniversary of the vesting commencement date and the remaining 75% of the shares vesting in substantially equal monthly installments over the following 36 months, subject to the new employee's continued service with Arena through the applicable vesting dates. The inducement RSUs vest over four years, with 25% of the shares vesting on the first quarterly vesting date on or following the one-year anniversary of the vesting commencement date and the remaining 75% of the shares vesting in 12 substantially equal quarterly installments occurring on the following 12 quarterly vesting dates, subject to the new employee's continued service with Arena through the applicable vesting dates. The inducement stock options and inducement RSUs are subject to the terms and conditions of Arena's Amended and Restated 2020 Long-Term Incentive Plan.
More on The Californer
About Arena Pharmaceuticals
ARENA Pharmaceuticals is a team with a singular purpose – deliver our important medicines to patients.
In a rapidly changing global market, we work with a sense of urgency every day to understand the needs of all our stakeholders, identify bold, sometimes disruptive, ideas to get our medicines to patients, and relentlessly execute until it's done.
ARENA - Care More. Act Differently.
Forward-Looking Statements
Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about Arena's purpose, work, understanding, ideas, and execution. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include those disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.
More on The Californer
Corporate Contact:
Megan E. Knight
Arena Pharmaceuticals, Inc.
Director, Investor Relations
[email protected]
858.210.3635
Arena Media Contact:
[email protected]
858.453.7200
SOURCE Arena Pharmaceuticals, Inc.
Related Links
http://www.arenapharm.com
The inducement stock options are non-qualified stock options, have a seven-year term, have an exercise price of $69.25 per share, the closing price of Arena's common stock on the grant date, and vest over four years, with 25% of the shares vesting on the one-year anniversary of the vesting commencement date and the remaining 75% of the shares vesting in substantially equal monthly installments over the following 36 months, subject to the new employee's continued service with Arena through the applicable vesting dates. The inducement RSUs vest over four years, with 25% of the shares vesting on the first quarterly vesting date on or following the one-year anniversary of the vesting commencement date and the remaining 75% of the shares vesting in 12 substantially equal quarterly installments occurring on the following 12 quarterly vesting dates, subject to the new employee's continued service with Arena through the applicable vesting dates. The inducement stock options and inducement RSUs are subject to the terms and conditions of Arena's Amended and Restated 2020 Long-Term Incentive Plan.
More on The Californer
- Cabrillo Economic Development Corporation Celebrates Completion of Dolores Huerta Gardens
- Lightning Motorcycle's Next-Gen Prototype Hits 174 MPH on Its Lowest Performance Setting
- Long Beach Health Department Launches Early Childhood Mental Health Program to Support Families and Childcare Providers
- Dane Flanigan joins Raymond James in Pasadena as Financial Advisor
- Governor Newsom announces appointments, including new California Air Resources Board Chair
About Arena Pharmaceuticals
ARENA Pharmaceuticals is a team with a singular purpose – deliver our important medicines to patients.
In a rapidly changing global market, we work with a sense of urgency every day to understand the needs of all our stakeholders, identify bold, sometimes disruptive, ideas to get our medicines to patients, and relentlessly execute until it's done.
ARENA - Care More. Act Differently.
Forward-Looking Statements
Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about Arena's purpose, work, understanding, ideas, and execution. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include those disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.
More on The Californer
- Legendary Mitchell-Hedges Crystal Skull Arrives in Beverly Hills
- NEW power supply release from Kepco Dynatronix - HSP Advanced
- St. Augustine Honors Hispanic Heritage Month
- WesternU researchers show Osteopathic Manipulative Treatment improves efficacy of COVID-19 vaccine
- Vesica Health Receives AUA Guideline Inclusion
Corporate Contact:
Megan E. Knight
Arena Pharmaceuticals, Inc.
Director, Investor Relations
[email protected]
858.210.3635
Arena Media Contact:
[email protected]
858.453.7200
SOURCE Arena Pharmaceuticals, Inc.
Related Links
http://www.arenapharm.com
Filed Under: Business
0 Comments
Latest on The Californer
- America's SBDC Announces 2025-2026 Board of Directors
- Avoid Swirl Marks When You Get a Car Wash in Downey CA
- Freedom Flourishes in Dutch Capital on Destination: Scientology, Amsterdam
- Poncho Tha Popstar: The West's Next King
- Physician-Turned-Patient Launches Advocacy Campaign to Spotlight Disability Insurance Barriers
- Celebrity Chef Nicole Andrea Guzman Releases Her First Childrens Book
- Thorn Ridge® Creates a World of Legends & Lore
- Screenwriting Cruise Adds Howard Suber, Ph.D., to Inaugural 7-Day Screenwriting Lab at Sea
- Twice the Laughs: Comedy Star Don Barnhart Rotates Residency at Both Delirious Comedy Club Locations in Las Vegas
- Voices for Humanity Ignites a Revolution for Learning with Eva Rehorova
- Omnigarde AI-Powered Face Recognition Achieves Top Global Rankings in Prestigious NIST Evaluation
- Petitioner Urges White House to Issue Executive Order on Divorce Fairness
- Car Wash Deal in Downey CA Prices Starting from $8
- Dr. Vincent Malfitano Elected to Central Council of The Italian Catholic Federation, National Gov
- Your Body Isn't Broken—It's Out of Balance: The New Book Revealing the Blueprint to Restore Hormone Balance, Sleep, Gut & Metabolic Health
- Long Beach Recognizes September as National Preparedness Month, Relaunches Program to Connect Neighborhoods to Disaster Planning Resources
- SEEAG Adds Santa Barbara County Office, Student & Community Agriculture Learning Programs
- California claims victory – again – over Huntington Beach as appeals court rules against city's NIMBY violations of state law
- The Great Junk Hunt Returns to Roseville – A Vintage Shopping Adventure Awaits!
- Erdos Technologies CEO Dan Herbatschek Emphasizes the Importance of Software in Helping Companies Make More Intelligent Decisions on Inventory Flow and Management